Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

RESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc.

US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna (NASDAQ:MRNA) by the ...

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...

EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...